Two near-term data catalysts expected in 2023
Entered active collaboration with Alvogen Pharmaceuticals and Lotus Pharmaceuticals for global development and commercialization of NRX-101 in suicidal. -Today at 04:10 pm- MarketScreener
Two near-term data catalysts expected in 2023 Entered active collaboration with Alvogen Pharmaceuticals and Lotus Pharmaceuticals for global development and.
No two people experience bipolar disorder the same way. Research suggests the disorder affects males and females differently, including types of symptoms and more.